Early-onset low-grade papillary carcinoma of the bladder associated with Apert syndrome and a germline FGFR2 mutation (Pro253Arg).

American journal of medical genetics. Part A ·Vol. 140 ·No. 20 ·2006-10-15 ·Pages 2245-7

Andreou A, Lamy A, Layet V, Cailliez D, Gobet F, Pfister C, Menard M, Frebourg T

Abstract

暂无摘要

MeSH Terms

Acrocephalosyndactylia/genetics,pathology Carcinoma, Papillary/genetics,pathology Child, Preschool Female Humans Mutation, Missense/genetics Receptor, Fibroblast Growth Factor, Type 2/genetics Urinary Bladder Neoplasms/genetics,pathology

Chemicals

FGFR2 protein, human Receptor, Fibroblast Growth Factor, Type 2

Authors & Affiliations

8 authors, click to expand affiliations / ORCID

Andreou Andréas

Department of Urology, Rouen University Hospital, Rouen, France.

Lamy Aude

Layet Valérie

Cailliez Daniel

Gobet Françoise

Pfister Christian

Menard Michel

Frebourg Thierry

Article Info

Journal

American journal of medical genetics. Part A

Abbr.

Am J Med Genet A

ISSN

1552-4825

DOI

10.1002/ajmg.a.31430

Published

2006-10-15

Pages

2245-7

Language

English

Region

United States

NLM ID

101235741

Subset

External Links

PubMed source DOI: 10.1002/ajmg.a.31430 View journal details

Analysis Services

Early-onset low-grade papillary carcinoma of the bladder associated with Apert syndrome and a germline FGFR2 mutation (Pro253Arg).

Contact

WeChat Official Account